Doyugan, Katherine D.
HRN: 19-29-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2025
CEFUROXIME 500MG (TAB)
11/19/2025
11/26/2025
PO
500mg
BID X 7 Days
S/P Classical CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes